Abuse Potential of Mild Analgesics
It is generally held that drugs such as heroin and morphine, as well as other narcotic analgesics, share certain pharmacological properties which are indicative of their ability to produce dependence of the morphine type (1–4). These properties of morphine and morphine-like drugs are (a) the production of a characteristic set of subjective effects and euphoria, and (b) the production of physical dependence. The exact relationship and relative importance of these pharmacological properties to the initiation and maintenance of “addiction” are not clear since the pathophysiology of addiction is a matter of great debate.
KeywordsSubjective Effect Physical Dependence Abuse Potential Narcotic Analgesic Abrupt Withdrawal
Unable to display preview. Download preview PDF.
- 2.Martin, W.R.: Assessment of the dependence producing potentiality of narcotic analgesics. In Radouco-Thomas, C. and Lasagna, L. (Eds.): International Encyclopedia of Pharmacology and Therapeutics, pp. 155–180, Ch. 9, Sec. 6, Vol. I, Pergamon Press, Glasgow, 1966.Google Scholar
- 3.World Health Organization: Evaluation of dependence-producing drugs. Report of a WHO Scientific Group. Wld. Hlth Org. Techn. Rep. Ser. 287, 1964.Google Scholar
- 5.Fraser, H.F. and Isbell, H.: Pharmacology and addiction liability of dl-and d-propoxyphene. Bull. Narcotics 12: 9–14, 1960.Google Scholar
- 6.Fraser, H.F., Martin, W.R., Wolbach, A.B. and Isbell, H.: Addiction liability of an isoquinoline analgesic, 1-(p-chloro-phenethyl-2-methyl-6,7-dimethoxy1,2,3,4-tetrahydroisoquinoline.) Clin. Pharmacol. Ther. 2: 287–299, 1961.Google Scholar
- 7.Jasinski, D.R., Martin, W.R. and Hoeldtke, R.: Studies of the dependence-producing properties of GPA-1657, profadol, and propiram in man. Clin. Pharmacol. Ther. 12: 613–649, July-Aug. 1971.Google Scholar
- 8.Fraser, H.F. and Isbell, H.: Human pharamacology and addictiveness of ethyl-1-(3-cyano-3,3-phenylpropyl)-4-phenyl-4-piperidine carboxylate hydrochloride (R-1132, Diphenoxylate). Bull. Narcotics 13: 29–43, Jan-Mar. 1961.Google Scholar
- 9.Lasagna, L. and Beecher, H.K.: The analgesic effectiveness of nalorphine and nalorphine-morphine combinations in man. J. Pharmacol. Exp. Ther. 112: 356–363, 1964.Google Scholar
- 10.Martin, W.R., Fraser, H.F., Gorodetzky, C.W. and Rosenberg, D.E.: Studies of the dependence-producing potential of the narcotic antagonist 2-cyclo-propylmethyl-2’-hydroxy-5,9-dimethyl-6,7-benzomorphan (cyclazocine, Win 20,740,ARC II-C-3). J. Pharmacol. Exp. Ther. 150: 426–436, 1965.PubMedGoogle Scholar
- 13.Jasinski, D.R., Martin, W.R. and Hoeldtke, R.D.: Effects of short-and long-term administration of pentazocine in man. Clin. Pharmacol. Ther. 11: 385–403, May-June 1970.Google Scholar